Pilot study on glycaemic variability in type 2 diabetes mellitus patients with basal insulin and fixed combo oral antidiabetic treatment.

Trial Profile

Pilot study on glycaemic variability in type 2 diabetes mellitus patients with basal insulin and fixed combo oral antidiabetic treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2011

At a glance

  • Drugs Antihyperglycaemics; Insulin; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Aug 2008 Primary endpoint identified as self monitoring blood glucose values as reported by ClinicalTrials.gov.
    • 05 Aug 2008 The expected completion date for this trial is now 1 May 2006 as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top